Treatment and monitoring of patients with lupus nephritis.
Balow
J E
JE
NIDDK, National Institutes of Health, Bethesda, MD 20892.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008181:Lupus Nephritis / Q000503:physiopathology / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide